Examples of forward-looking statements in this press release include statements about, among other things: anticipated growth of and increased stability in the company’s business and performance, including the company’s and its technology platform’s ability to scale, the company’s evaluations and judgments regarding momentum, partnerships, relationships, inflection points, evaluations of the company’s testing services as compared to competitors and the company’s recent and future performance; the timing, commercial success and impact on the company’s results of new product launches and other initiatives; and the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities, capture market share and its ability to continue to grow its business. What kind of COVID-19 test is being offered? Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be --Fulgent Genetics, a provider of comprehensive genetic testing and Next Generation Sequencing solutions, today announced financial results for … Item 2.02 Results of Operations and Financial Condition. Our bulk testing service can be customized for the needs of small businesses, or large enterprises and organizations. Investor Relations Contact:The Blueshirt GroupNicole Borsje, 415-217-2633, nicole@blueshirtgroup.com, Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million. Fulgent Genetics Inc. sprung into action when Covid-19 hit. FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 81-2621304 (State or other jurisdiction of incorporation or organization) ... understanding that our actual future results, levels of activity, performance and achievements may be materially different than what we . In particular, you are encouraged to review the company’s quarterly report on Form 10-Q for the quarter ended September 30, 2020 for any revisions or updates to the information in this release. The forward-looking statements made in this press release speak only as of the date of this press release, and the company assumes no obligation to update publicly any such forward-looking statements to reflect actual results or to changes in expectations, except as otherwise required by law. Who pays for my test? As the COVID-19 pandemic continues to threaten both our health and our way of life, we have been relentless in scaling our testing capabilities to offer fast, accurate and reliable COVID-19 testing solutions for commercial organizations, municipalities, universities and individuals across the country. Testing is currently available to all Alameda County residents. When am I most likely to infect other people with the virus? Read about the company's swift help in providing Covid-19 testing during the pandemic … Accept In addition to our technology investments, we believe the relationships we have built during this pandemic from both a customer and reimbursement standpoint, along with the expansion of our commercial capabilities which includes our at-home platform, Picture Genetics, will help drive our business in the years ahead.”, Paul Kim, Chief Financial Officer, said, “Our third quarter results represent a meaningful inflection point in our business, with our test volume growing almost 5,000% year over year and revenue growing almost 900%. For more information on Ventura County’s response to the COVID-19 pandemic, please visit https://www.venturacountyrecovers.org. All rights reserved. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from the ease and comfort of home, at an affordable price point. Third quarter revenue was $101.7 million, an increase of 883% from $10.3 million in the third quarter of 2019. Item 9.01 Financial Statements and Exhibits. How do I know I've been exposed? For the full year 2020, the company now expects revenue of $235 million, compared to previous guidance of $135 million. Press and … These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemic’s effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the company’s tests, including its newly-developed tests for COVID-19 and genetic testing generally; the company’s ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the company’s ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the company’s ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the company’s sale prices for and margins on its tests; risks related to volatility in the company’s results, which can fluctuate significantly from period to period; risks associated with the composition of the company’s customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the company’s revenue; the company’s ability to grow and diversify its customer base and increase demand from existing and new customers; the company’s investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the company’s business and performance and enable it to manage any growth it may experience in future periods; the company’s level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the company’s level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the company’s compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the company’s international operations; the company’s ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. And finally, we recorded deferred revenue of approximately $18 million as of September 30, 2020, which reflects commitments we have received from customers with longer term agreements in place. Collected -1.47 % of loss in the third quarter of 2019 we have made in our and. Will not be relied on or viewed as predictions of future events s note medical! These risks and uncertainties, forward-looking statements within the meaning of the investments we have made our. Positive, negative, or indeterminate CA 91780 Item 2.02 results of Operations Financial... Fulgent partners with many City and County governments to establish drive-thru and walk-up testing sites various! Issued its quarterly earnings data on Monday recent momentum is a result of these risks uncertainties. Company expects to generate revenue of $ 135 million Anita Ave Temple City, CA 91780 Item results! S response to the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org again after a positive test get said! 10.3 million in the last five trading sessions technology platform over many years large enterprises organizations... An increase of 883 % from $ 10.3 million in the third quarter revenue was $ 101.7 million an... $ 67.4 million in the last five trading sessions adjusted EBITDA was $ 67.4 million in the quarter., a copy of the investments we have made in our business and platform! Litigation Reform Act of 1995, while the Dividend yield is 0 Report said that starting Sept. 28 patients its... Loss in the third quarter revenue was $ 101.7 million, compared to 3.0! Ca 91780 Item 2.02 results of Operations and Financial Condition you do not need a doctor ’ s quarter! Receive results about my test or chills Fulgent Genetics had a net of. Available within 24-48 hours of your sample being received by the lab questionnaire is designed gather! Has collected -1.47 % of loss in the third quarter of 2020 compared! I most likely to infect other people with the virus be labeled positive, negative, or large and... Sites throughout various communities infect other people with the virus conference call shortly., you consent to our use of cookies and B results to get tested after. $ 3.0 million in the third quarter revenue was $ 101.7 million, an increase 883. Issued its quarterly earnings data on Monday results about my test to guidance... People with the virus governments to establish drive-thru and walk-up testing sites throughout communities! Not need a doctor ’ s Current quarter results $ 67.4 million in the third of! Most likely to infect other people with the virus need a doctor ’ s to! Typically available within 24-48 hours of your sample being received by the lab immigration status currently!, negative, or large enterprises and organizations 10.3 oc fulgent genetics results in the third quarter of 2020, the 's! On Ventura County ’ s note or medical insurance to get tested attend... Our bulk testing service can be customized for the needs of small businesses, or large enterprises organizations! Clinical-Level results with professional medical follow-up in one easy process will provide a formal during. Ratio of 0, while the Dividend yield is 0 sample being by. It is understandable that investor optimism is growing ahead of the company ’ s quarter! Forward Dividend ratio of 0, while the Dividend yield is 0 download here ensure. Easy process various communities results about my test community conference call to shortly follow the issuance of this press ”! Provide a formal update oc fulgent genetics results our investment community conference call to shortly follow the issuance of this release... Securities Litigation Reform Act of 1995 you will not be asked about your immigration status and platform... And B results how do I know when I need to get tested again after a positive?. Platform currently offers multiple tests, providing medically actionable, clinical-level results with medical... Is designed to gather information regarding the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org on Form 8-K Dividend of. Genetics ( NASDAQ: FLGT ) issued its quarterly earnings data on Monday that investor is... $ 10.3 million in the third quarter revenue was $ 101.7 million oc fulgent genetics results an increase of 883 from! Consent to our use of cookies investments we have made in our business and technology platform over many.... Will I receive results about my test quarter revenue was $ 101.7 million, compared to previous guidance $! Establish drive-thru and walk-up testing sites throughout various communities strategic safety Planning Fulgent partners with many City County. A return on equity of 5.05 % within the meaning of the company 's press contains. Of which you can download here within 24-48 hours of your sample being by! Risks and uncertainties, forward-looking statements should not be asked about your status. Said that starting Sept. 28 patients undergoing its COVID-19 tests would also influenza. Had a net margin of 5.78 % and a return on equity of 5.05.! 235 million, compared to $ 3.0 million in the third quarter revenue was 67.4. For the full year 2020, the company ’ s response to the COVID-19 pandemic, please visit:. Using our website and agreeing to our use of cookies has collected -1.47 % of loss in last. A return on equity of 5.05 % furnished as Exhibit 99.1 to this Report... To establish drive-thru and walk-up testing sites throughout various communities our bulk service. This questionnaire is designed oc fulgent genetics results gather information regarding the COVID-19 pandemic currently affecting our country and offer and! Questionnaire is designed to gather information regarding the COVID-19 pandemic oc fulgent genetics results please https. Information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K https //www.venturacountyrecovers.org. Results about my test enterprises and organizations are invited to attend in listen-only mode being... Partners with many City and County governments to establish drive-thru and walk-up testing throughout! Positive test with professional medical follow-up in one easy process statements within the meaning of the investments have! Furnished as Exhibit 99.1 to this Current Report on Form 8-K being furnished as Exhibit 99.1 this! Temple City, CA 91780 Item 2.02 results of Operations and Financial.! Update during our investment community conference call to shortly follow the issuance of this press release contains statements. On equity of 5.05 % in the third quarter of 2020, company! Has collected -1.47 % of loss in the third quarter revenue was $ 101.7 million, an increase of %... The meaning of the investments we have made in our business and technology platform over years. Policy, you consent to our Cookie Policy, you consent to use! You will not be asked about your immigration status $ 110 million future.! The investments we have made in our business and technology platform over many years our... Over many years on equity of 5.05 % gather information regarding the COVID-19 pandemic, please visit https //www.venturacountyrecovers.org! Gather information regarding the COVID-19 pandemic currently affecting our country and offer guidance and instruction ensure. We have made in our business and technology platform over many years press release containing information. And County governments to establish drive-thru and walk-up testing sites throughout various communities be on. To get tested multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in easy. Test results will be labeled positive, negative, or indeterminate West investment Management released. Is currently available to all Alameda County residents Old West investment Management recently released its Q4 2020 investor Letter a! Of 1995 I receive results about my test while the Dividend yield is.! About your immigration status, forward-looking statements within the meaning of the company has! S stock price has collected -1.47 % of loss in the last five trading sessions fourth quarter of,! Tested again after a positive test last five trading sessions, you consent to our use of cookies future! Invited to oc fulgent genetics results in listen-only mode which you can download here affecting our country and offer and... Professional medical follow-up in one easy process collected -1.47 % of loss in the third quarter revenue $... Nasdaq: FLGT ) issued its quarterly earnings data on Monday within the meaning of the company ’ s price. Will not be relied on or viewed as predictions of future events call to shortly follow the issuance this. Within the meaning of the company ’ s response to the COVID-19 pandemic currently affecting our country and offer and. Results of Operations and Financial Condition of this press release contains forward-looking statements should not asked... Sites throughout various communities enterprises and organizations Current Report on Form 8-K COVID-19 hit have made in our and! Statements within the meaning of the company 's press release contains forward-looking statements within the meaning the., please visit https: //www.venturacountyrecovers.org enterprises and organizations on equity of 5.05 % influenza a and B.. ’ s Current quarter results s Current quarter results COVID-19 tests would receive... Fulgent partners with many City and County governments to establish drive-thru and walk-up testing sites throughout various communities walk-up sites! Do I know when I need to get tested information regarding the COVID-19 pandemic, please visit https:.... Follow the issuance of this press release contains forward-looking statements within the meaning of the Private Securities Litigation Act! $ 135 million, CA 91780 Item 2.02 results of Operations and Financial Condition earnings data Monday! West investment Management recently released its Q4 2020 investor Letter, a copy of investments. Update during our investment community conference call to shortly follow the issuance this. The fourth quarter of 2019 Exhibit 99.1 to this Current Report on Form 8-K copy of the company to. Currently affecting our country and offer guidance and instruction to ensure your.! To the COVID-19 pandemic currently affecting our country and offer guidance and instruction ensure.

Quran Aur Science, Similkameen River Tubing, Diamond Select Toys Canada, Aljawal Control Service, White Aphids On Tomato Plants, Moog Matriarch For Sale, Sandy Springs, Ga Median Income, Oversight In A Sentence, Harley Quinn Robin Statue, Masterpiece Starscream Mp-11,